MTOR and pancreatic neoplasm: And in murine models of pancreatic cancer, IL-18-induced activation of the PI3K-Akt/mTOR pathway leads to the exhaustion of intratumoral CD8+ T cells (68), suggesting that mTOR inhibition mediated by DDIT4 may potentially ameliorate this process.